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Abstract
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Managing chronic pain effectively is often challenging for health care providers and patients.
Telehealth technologies can bridge geographic distance and improve patients' quality of care in
communities where access to pain specialists has previously been unavailable. This paper
describes the development and evaluation of a telehealth intervention (TelePain) designed to
address the need for pain specialist consultation regarding pain and symptom management issues
in non-academic medical centers. We describe the theoretical foundation and development of a
multifaceted intervention using a cluster randomized clinical trial design. Health care providers
and their patients with chronic pain are enrolled in the study. Patient participants receive the
intervention (report of symptoms and receipt of a pain graph) weekly for 8 weeks and are
contacted at 12 weeks for completion of post-intervention follow-up measures. Their providers
attend Telepain sessions which involve a didactic presentation on an evidence-based topic related
to pain management followed by patient case presentations and discussion by community
clinicians. Symptom management recommendations for each patient case are made by a panel of
pain specialists representing internal medicine, addiction medicine, rehabilitation medicine,
anesthesiology, psychiatry, and nursing. The outcomes assessed in this randomized trial focus on
pain intensity, pain's interference on function and sleep, and anxiety, depression, and costeffectiveness. Some of the challenges and lessons that we have learned early in implementing the
TelePain intervention are also reported.

Keywords
pain; symptom management; randomized trial; telehealth

© 2014 Elsevier Inc. All rights reserved.
*

Corresponding author at: School of Nursing, University of Washington, Box 357266, Seattle, WA 98195, USA. Tel.: +1 206 616
9396; fax: +1 206 543 4771.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Eaton et al.

Page 2

Background
NIH-PA Author Manuscript

Approximately 100 million adults in the United States are affected by chronic pain.1 The
prevalence of chronic pain in adults in the United States has been estimated to range from
14.6% to 64%.2–5 The prevalence has been found to be higher among females (34.3%) than
males (26.7%), to increase with age, and is most often due to non-specific lower back pain
followed by osteoarthritis pain.2
Pain lowers patients’ work productivity, requires patients to seek medical treatment, and
complicates treatment for other health problems; thus, its economic costs are high in the
United States.6 Using the 2008 Medical Expenditure Panel Survey, Gaskin and Richard6
found the total costs—U.S. health care costs attributable to pain and the annual costs of pain
associated with lower worker productivity—ranged from $560 to $635 billion in 2010
dollars. This cost is greater than each of the annual costs for heart disease, cancer, and
diabetes.6
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Chronic pain may often be managed with opioid therapy. Escalating prescription opioid use
and abuse have emerged as major public health problems. This escalation may be related to
more deaths due to opioid misuse than to traffic fatalities, and in a ten-fold increase in drug
abuse treatment admissions for opioids.7 Washington State’s 2012 opioid prescribing rules
now require pain specialty consultations for high-dose patients, i.e., patients receiving more
than 120 mg/day of morphine or equivalent.8
Managing chronic pain effectively is challenging and requires health care providers who are
knowledgeable in both pharmacologic and nonpharmacologic treatment for pain. Because
pain management interventions are individualized to each patient, health care providers must
have an understanding of the realm of interventions to best manage pain. Provider pain
management education is needed as indicated by findings from a recent survey of 856
primary care physicians and advanced registered nurse practitioners in Washington State. 9
The survey, which focused on changes in practice patterns and use of support tools in the
prescription of opioids for the treatment of chronic noncancer pain, found the majority of
providers needed access to “more efficient, innovative means of support and education
related to treating patients with chronic noncancer pain, such as telemedicine consultation.”9
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Rural Pain Management
Many rural communities in the United States are disadvantaged by limited access to pain
medicine specialists, and inadequate pain medicine training and support for community
health care providers.10 These communities are also experiencing economic decline and an
aging population base.11 Meanwhile, their health care organizations are in a vulnerable
position: they face financial challenges due to low population densities, few economies of
scale, and high rates of fixed costs per service, yet they need to provide sufficient financial
and quality-of-life incentives to retain providers to adequately meet the needs of their
communities. Additional issues that can adversely impact retention of providers in rural
areas include professional isolation and lack of access to continuing medical education.12
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Rural residents are more likely than their urban counterparts to be in poorer overall health,
suffer from more multiple chronic or serious illnesses and disabilities, be uninsured or
under-insured, be living in poverty, be older, have less formal education, and lack social
support and a regular source of health care.12 Access to health care is often hampered by
long travel distances, which is exacerbated by poor secondary roads and winters with
inclement weather conditions. Rural residents often experience delays in obtaining care that
is not available locally.14 Furthermore, in many cases, rural residents are required to leave
the supportive environment of family and community to obtain care available in urban
settings. These residents may benefit by programs that provide local health care providers
with access to pain management education and consultation; thus, improving the quality of
care within the community.
Telehealth and Pain Management
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Telehealth technologies can bridge geographic distance and increase patients’ quality of care
in communities where specialized health care has previously been unavailable. The growth
of technological innovations such as high-capacity digital networks, powerful computer
hardware and software, high-resolution digital image compression, and the Internet has had
a great impact on the process of health care delivery and has introduced ways to increase
rural populations’ access to specialized care services. Studies show that telehealth offers
positive outcomes and high satisfaction for patients, primary care providers, and specialist
consultants.15–20
The economic consequences of telehealth have been examined in several settings including
home settings for patients with chronic conditions such as congestive heart failure.21
Findings indicate the potential for cost savings exists through reductions in rehospitalization
rates and unexpected use of health care services such as emergency department services.22
Additionally, providers are able to bill for management of higher levels of care provision as
their confidence for managing complex cases increases. Telehealth’s effect on health care
utilization and pain management outcomes and its associated cost-effectiveness, however,
has not been explored.
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The use of telehealth technology to discuss treatment options with a specialist is welldeveloped for chronic pain management.23 Project ECHO (Extension for Community Health
Outcomes) is an example of a successful telehealth program that provides chronic pain
management education and consultation to health care providers in rural and underserved
communities.24, 25 This program has shown significant improvements in providers’ selfreported knowledge, skills and practice;24 however, it is not known what effect this type of
program has on patient outcomes.
Using telehealth to improve pain care was first piloted at the University of Washington
(UW) in 2006 as part of a project with American Indian communities, funded by Health
Resources and Services Administration’s (HRSA) Office for the Advancement of
Telehealth.26,27 The project included 9 tribal clinics in Washington state and 26 clinics in
Alaska. The telehealth system was found to be a successful method for delivering services to
tribal clinics. In 2009, the project was expanded through an NIH grant to include rural
hospitals and clinics.28 In 2011, it merged with Project ECHO.
Contemp Clin Trials. Author manuscript; available in PMC 2015 July 01.
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The purpose of this study is to develop and test a telehealth-enhanced symptom management
intervention (TelePain) designed to advance and improve access to quality pain and
symptom management care for community populations. This study examines both patient
and provider outcomes of a telehealth provider education and consultation program. We
describe the theoretical foundation and development of this multifaceted intervention as well
as the design of a randomized clinical trial to evaluate TelePain. We also report some of the
lessons learned in implementing this study.

Theoretical Foundation of the Intervention
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The symptom-management approach is based on the Symptom Management Conceptual
Model. The model comprises three domains (person, health/illness, and environment) which
influence the model’s three dimensions (symptom experience, management strategies, and
outcomes).29 The person domain includes individual characteristics. The health/illness
domain includes health status, risk factors, and disease and injury. The environment domain
includes physical, social, and cultural characteristics. The symptom experience dimension is
the individual’s perception of a symptom. The management strategies dimension includes
specifications of the interventions, such as taking oral pain medication every six hours. The
outcomes dimension focuses on functional status, self-care, costs, quality of life, morbidity
and comorbidity, mortality, and emotional status. The model is based on the premise that all
three dimensions must be considered for effective symptom management.
In this study, the person domain is an adult; the health/illness domain is pain; and the
environment domain is the home setting in the community. The proposed pain and symptom
management intervention addresses all three domains of the conceptual model, thus
providing a holistic and effective approach to symptom management.

Overview of the Study
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This study, approved by the UW institutional review board (IRB), uses a cluster randomized
trial of a telehealth-enhanced symptom management intervention for chronic pain
management (figure 1). This is the first study to our knowledge to use an experimental
design to explore the cost-effectiveness of a telehealth-enhanced intervention in chronic pain
management. The telehealth platform of our study intervention provides an innovative
approach to an unaddressed problem: the need for efficient and cost-effective chronic pain
and symptom management in communities.
The study is designed to answer the main question: For community patients, does a
telehealth-enhanced pain and symptom management intervention provide better pain
management than the current usual care? The economic research question is: From a societal
perspective, should community health care organizations that care for adult patients invest in
telehealth-enhanced symptom management as a cost-effective alternative to the current
usual care?
The study aims include: (a) to evaluate the effectiveness of the telehealth-enhanced chronic
pain management intervention on pain severity among patients at 2 months compared to the
standard care group, (b) to evaluate the effectiveness of the intervention on fatigue, dyspnea,
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constipation, anxiety, depression, and quality of life among patients at 2 months compared
to the standard care group; (c) to evaluate the effectiveness of the intervention on provider
knowledge and attitudes regarding pain and on providers’ perceived competence in treating
symptoms at 3 months compared to the standard care group; and (d) to establish the costeffectiveness of the intervention from a societal perspective (the incremental cost per
quality-adjusted life year [QALY] gained), by incorporating the cost of the intervention and
the impact on health care utilization, patient travel and time costs, and caregiver time costs.
Patient participants receive the intervention (report of symptoms and receipt of a pain graph)
weekly for 8 weeks and are contacted at 12 weeks for completion of post-intervention
follow-up measures. Their health care providers present their clinical case at the TelePain
video conference to a panel of academic pain specialists within the first 4 weeks of the
patient’s study enrollment. At the end of the patient’s study participation, their case is
presented again as follow-up. The one month follow-up interval, i.e., 3 months after
enrollment in the study, was selected because patients would be seen again by their health
care provider at this time point. The standard care group patients provide a report of their
pain and other symptoms every 2 weeks for 8 weeks and at week 12 for completion of
follow-up measures.

NIH-PA Author Manuscript

The interdisciplinary research team includes the nurse scientist principle investigator and coinvestigators: a palliative care expert physician, a pain management expert physician, a
psychologist, a health care economist, and a biostatistician. The team is completed by two
research nurses, two research assistants, a doctorally-prepared nurse pain management
expert, and the director of the UW Telehealth Services.

Description of the Intervention
The telehealth-enhanced symptom management intervention (TelePain) uses low-cost,
commercially available technology as its mode of delivery. The intervention has three
components: (a) video case conferences between community health care providers and pain
and symptom management experts to manage cases and engage community providers in
evidence-based practice resources and peer support, (b) weekly report of pain and other
symptoms using a Web-based patient reported outcome instrument, and (c) weekly graphs of
patients’ reported pain experience.

NIH-PA Author Manuscript

Video Case Conferences
Videoconferencing is used for case-based learning to improve community health care
providers’ ability to manage more complex cases, reinforce evidence-based practice, and
model an interdisciplinary approach to care. Expert symptom management consultants from
UW provide weekly 90-minute case conferences via videoconference for community health
care providers in the intervention group. The teleconsultant team participating in each
telepain session includes specialists whose expertise spans pain medicine, internal medicine,
anesthesiology, rehabilitation medicine, psychiatry, addiction medicine, nursing, and
complementary and integrative pain management. In addition to receiving the teleconsultant
team’s recommendations, community health care providers have the opportunity to learn
from each other through provider interaction during the videoconference. The video case
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conferences also offer brief didactic presentations on core topics essential to chronic pain
care (see Table 1) and continuing medical education (CME) credits. The topics were
identified from the International Association for the Study of Pain Curriculum Outline on
Pain for Medicine.30 One topic is covered each week and its selection is based on speaker
availability. Provider study participants have attended a range of 1–20 telepain sessions; thus
receiving a range of 1.5–30 CMEs per provider.
The community health care provider submits information about each patient who is
participating in the study within the first four weeks of the patient’s study enrollment. This
information is submitted by fax to the teleconsultant team no less than a day in advance of
the video case conference. The community health care provider submits the patient history,
including diagnosis, current medical issues, current symptom management issues, and
specific questions for the consulting team. All identifying information is omitted and the
patient is referred to only by an assigned patient number.

NIH-PA Author Manuscript

The teleconsultant team makes recommendations for difficult pain and symptom
management issues which include behavioral, lifestyle, rehabilitative, cognitive, and
pharmacological strategies. The latter focuses on minimizing side effects and maximizing
symptom control. Tailored interventions are identified to manage pain effectively. The
consultants also provide guidelines on how to assess and manage symptoms over time, as
well as when to respond to symptoms and when to practice “watchful waiting.”
Recommendations are based on guidelines from the Agency Medical Director’s Group31,
the American Academy of Pain Medicine32, the American Pain Society33, and the
Federation of State Medical Boards.34 A summary of the recommendations is faxed and emailed to the community health care provider. The provider shares the recommendations
with the patient at his or her next visit. The patient’s preferences and the provider’s clinical
judgment are considered in determining which recommendations to implement. The
community health care provider gives a follow-up presentation of the patient at the end of
the patient’s study period, approximately at week 12. An example of a telepain case and
consultants’ recommendations is provided in Table 2.
Patient Report of Symptoms
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The study intervention includes a weekly report of patient symptoms from home via a
reporting system through the Internet, a novel multimodal UW Pain tool. If patients are not
comfortable using the Internet, they may choose to report their symptoms by phone or on a
paper version. If the patient chooses to report by phone, they are called by the research team
weekly for 8 weeks and the Web-based patient reported outcome instrument is completed
over the phone. If the patient chooses the paper version, a hard copy of the survey is mailed
to the patient and they are instructed to return the survey by mail in a postage-paid envelope
provided to the patient. Patients who have chosen the paper version have been highly
motivated and the response rate has been 100%.
Graphs
The patient’s pain experience is visually depicted in a graph format which is generated
weekly for the patient to view. The graph provides three aspects of the patient’s pain
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experience: (a) pain intensity and distress, (b) pain interference and difficulty performing
one activity important to the patient, and (c) pain interference with falling asleep and staying
asleep. Depending on which version of the symptom reporting system is used, either the
patient or the research team generates the graph. Patients are then instructed to share and
discuss the graph with their community health care provider at their next clinic visit. At
week 8, patients are asked (a) if they found the graph helpful and if yes, what was helpful,
(b) if they shared the graph with their provider -- if no, why not and if yes, what was
discussed and what changes were made to their pain management plan. Standard care group
patient participants are mailed a graph when they complete the study at week 12.

Implementation
The community health care provider is the unit of randomization in this cluster-randomized
design. After completing the baseline questionnaires, providers from community clinics are
randomized to the treatment or standard care group by the study biostatistician. Patients are
assigned to the same group as their provider.

Participant Eligibility, Recruitment, and Incentives
NIH-PA Author Manuscript

Providers
The community health care providers are from Washington State, Wyoming, Alaska,
Montana, and Idaho. Eligible providers include physicians, physician assistants, nurse
practitioners, and registered nurses who provide direct care to patients with chronic pain.
After the provider’s clinic submits a letter of support to the UW IRB, providers are
consented by their reading of the study information statement on the study website. The
research team’s phone numbers are listed so providers can contact a research team member
to ask questions about the study. Consent is indicated through completion of the baseline
measures collected via the Internet. This consent process allows us to successfully reach
distant geographical areas.

NIH-PA Author Manuscript

Following randomization, the providers identify eligible patients in their caseload using the
following criteria: (a) ≥ 18 years of age, (b) diagnosed with pain, (c) completion of an
outpatient visit in the past 2 months, (d) functional fluency in English, (e) no or only mild
cognitive impairment, and (f) no problems with regular phone lines because of hearing
assistive devices. Eligible patients are asked by their provider if they are interested in being
contacted about this study. If patients agree to be contacted by the research team, the
provider gives their name and phone number to the research team via fax, phone, or e-mail.
Providers receive $100 for participating in the study. If two of the provider’s patients agree
to participate in the study, the provider will receive an additional $100 check for their time.
For each additional patient who agrees to participate, the provider will receive a $100 check.
Providers in the intervention group also receive free CME credits for each UW TelePain
video case conference attended. An additional incentive for Washington providers is that the
teleconsultation meets the state’s 2012 opioid prescribing rules requirement for pain
specialty consultations for high-dose and high-risk patients.
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Providers receive weekly e-mails from the research team to request patient referrals and to
notify them of which patients are currently participating in the study. Providers may have up
to 15 patients enrolled in the study.
Patients
Interested patients are contacted by phone by a research nurse who reads the consent form to
them and answers questions regarding the study. If the patient agrees to participate in the
study, they are screened for eligibility and baseline measures are collected by the research
nurse. Patients are asked to choose which symptom reporting system they would like to use:
Internet, phone, or paper version. Patients who choose the Internet delivery method receive
verbal and written instructions for using this Web-based system. They create a password for
accessing the Web-based system and receive email reminders for completing the weekly
assessments. The participants who select the phone delivery method identify a convenient
day and time to be called by the research team. Patients are compensated $100 for
participating and receive a $25 check for completing the baseline survey, $25 for completing
the 8-week survey, and $50 for completing the 12-week survey.
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Study Measures
Provider Outcomes
The community health care provider completes the KnowPain-12 questionnaire35, the
Knowledge and Attitude Survey Regarding Pain36, and the Perceived Competency Scale37.
Providers complete the outcome measures at baseline and after their patients have completed
the study, at approximately 3 months (Table 3). Surveys are completed on the Internet via
the study Website.
Patient Outcomes
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The patient completes the symptom reporting system, which is a patient reported outcome
(PRO) Web-based tool that queries the patient about symptoms over the past week. The
symptom reporting system includes the PHQ-438,39; the Pain Intensity, Enjoyment of Life,
and Interference with General Activity (PEG) Numeric scales40, and items addressing
analgesic side effects, number of “bad days” when more medication than is prescribed was
needed, and treatment satisfaction. The symptom reporting system also includes the Opioid
Risk Tool (ORT)41 which is completed at baseline and available during video case
conferences to help providers assess risk of aberrant drug-related behavior where additional
monitoring is indicated. Additionally, the patient completes the HUI-342–45; Health
Resource Utilization Survey46; Work Productivity and Activity Impairment Questionnaire47
Caregiving Time48; and numeric scales for fatigue, shortness of breath, and constipation. All
of these outcome measures have established reliability and validity. The patient is also asked
about non-medicine pain relief methods used and what medications they are taking for pain,
anxiety, depression, sleep, and constipation. All patients are contacted by the research team
via phone to complete the baseline measures. Standard care patients complete the study
measures at weeks 2, 4, 6, 8, and 12. Surveys for both groups take approximately 5 to 15
minutes.
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Data collected from the video case conference presentations include the patient history and
clinical problems, expert recommendations, and follow-up information on recommendations
implemented and patient results. At 8 weeks, intervention patients complete the
Telemedicine Perception Questionnaire.49
Economic Data
In addition to the medication, health utilization, productivity and caregiver information
collected by the symptom reporting system, economic evaluation data are collected from the
clinic’s billing services and, if needed, from review of the patients’ medical records six
months after they complete the study. Obtaining cost data is challenging since it may require
collecting data from both paper records and the electronic medical record. Working closely
with the clinic’s billing services is key to obtaining economic evaluation data. We have
created a data collection tool which is used by the clinic’s billing services and by the
research team when completing medical record abstractions.

Analysis Plan
NIH-PA Author Manuscript

Overview of Analytic Approach
The conduct of the study and all analyses will be based on the intent-to-treat principle.
Analyses for patient outcomes will be by mixed-effect models using hierarchical linear
modeling (HLM).50,51 The primary outcome variable will be average pain in past week, as
reported on the symptom reporting system, measured at week 8. The model will include a
random provider effect and a fixed group effect. Baseline (pre-intervention) pain will be
included as a covariate.
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With 48 providers per treatment arm, 3 patients per provider, and an ICC of 0.2, the Design
Effect (Deff) = 1.4 and the effective sample size is 103 per treatment arm, reduced from 144
actual patients per arm. Based on a t-test comparing the two treatment arms (N = 103 per
arm), there is 82% power to detect a standardized effect size (i.e. the difference in means
between intervention and control arms, divided by the within-group standard deviation) of
0.4, and 95% power to detect a standardized effect size of 0.5. This study should have over
80% power for detecting a treatment effects on all of the outcome measures. These power
calculations are probably conservative, since they are based on a simple t-test while the
actual analysis will be by mixed model which accounts for the multiple weeks of outcome
data and controls for baseline pain and other possible baseline covariates.
Analyses for provider outcomes will be by analysis of covariance, comparing the two
treatment arms on provider knowledge and attitudes regarding pain, providers’ perceived
competence in treating symptoms, and the KnowPain-12 questionnaire responses as
measured at 3 months, and controlling for the baseline value of that measure as a covariate.
A description of the economic evaluation analysis plan has been previously published.48
Analyses for the economic evaluation will be supplemented with a secondary analysis based
on received treatment (i.e., patients in the intervention group who did not receive the
intervention as planned will be placed in the standard care group).
Contemp Clin Trials. Author manuscript; available in PMC 2015 July 01.
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Study Progress, Challenges, and Lessons Learned
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The study began enrolling patients in May 2012 and as of February 2014, we have enrolled
22 clinics, 26 providers, and 154 patients. The number of patients per provider ranges from
1 to 15 (mean = 6). Interim analyses are not being conducted in order to preserve a p value
of 0.05 for hypothesis testing of the primary outcome.
Lessons Learned
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It has been challenging to recruit healthcare organizations, providers, and patients.
Participating clinics have primarily been those that have a preexisting relationship with UW
Telehealth Services. Site visits have been very important to build relationships with clinics
and their providers. The most active provider participants have been those who have
administrative support for attending the TelePain sessions. An added incentive for
participating clinics is for providers to learn evidence-based pain management interventions
from specialists and the ability to bill for additional services by participation in TelePain.
For example, a provider could bill for a more complex service for subsequent visits provided
that the patient’s condition supports the enhanced level of service and the physician
mentions the case consultation in their documentation.
Scheduling time to attend TelePain sessions has also been challenging for both specialist
providers at the university setting and for the community health care providers. One of the
methods we have used to make the sessions more accessible is scheduling sessions either
early in the morning or over the lunch hour, so it is a “lunch and learn” session. As noted,
one incentive for providers is that they receive 1.5 hours of CME at no cost for participating
in TelePain, so providers are able to earn required CME hours without leaving their office.
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Providers are referring patients, but we have faced challenges with enrollment. Of the 227
eligible patients referred to the study, the research team was unable to reach 23 (10%)
patients by phone, and 50 (22%) patients declined to enroll due to reasons such as being too
busy, not interested, did not want medical records reviewed, currently participating in other
research studies, and study was too much of a time commitment. This is a complex study
population that may have limited self-management skills and chaotic social support and
lives. We have recently increased the patient incentive from $50 to $100, expecting that this
will improve patient enrollment.

Significance
Access to specialty care for pain patients living in the community is often difficult. The
majority of pain specialists are concentrated in urban areas, causing geographical barriers
that must be overcome as well as additional time and money constraints. Since a
consultation with a pain specialist is not available to most pain patients, participation by
their primary care provider in TelePain has been demonstrated as a feasible solution to
improving patients' quality of care. It is also an efficient solution for providers to learn about
evidence-based practices from university-based experts. TelePain bridges physical distances
through the use of video, Web, and telephone conferencing technologies to increase access
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to chronic pain management. This study will provide important empirical data on the use of
TelePain in providing chronic pain and symptom management in communities.
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CME

continuing medical education

HLM

hierarchical linear modeling

HRSA

Health Resources and Services Administration

HUI-3

Health Utilities Index-3

IRB

institutional review board

MSW

Master of Social Work

ORT

Opioid Risk Tool

PEG

Pain Intensity, Enjoyment of Life, and Interference with General Activity

PHQ-4

Patient Health Questionnaire-4

PRO

patient reported outcome

QALY

quality-adjusted life year, UW, University of Washington
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Schematic Diagram of Study Procedures
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Table 1
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Core and Supplemental Didactic Topics
Core Topics:

Supplemental Topics:

1

Taking a pain history; assessment and motivational interviewing

1

Medicinal cannabis

2

Functional assessment

2

Methadone

3

Addiction assessment

3

Sleep disturbances and chronic pain

4

Establishing a pain diagnosis

4

Disability

5

Risk screening tools for opioid safety

5

Complementary and alternative medicine

6

Urine drug testing use, interpretation, and response

6

Pain in children

7

Opioids and morphine equivalent dose calculation

7

Pain in older adults

8

Controlled substance agreements

8

Pain during pregnancy

9

Prescription Monitoring Program: how to access, use, and respond

9

10

Patient reported outcomes

11

Adjuvant analgesics (neuromodulators)

Primary care disorders (e.g., fibromyalgia,
headaches, osteoarthritis, low back pain,
diabetic peripheral neuropathy, visceral
abdominal and pelvic pain)

12

Anxiety as comorbid condition: assessment and treatment

NIH-PA Author Manuscript

13

Depression as comorbid condition: assessment and treatment

14

Posttraumatic stress disorder as comorbid condition: assessment and
treatment

15

Cognitive behavioral therapy

16

Exercise and pain
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Table 2
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Telepain Case Consultation Example
Initial Case Presentation: 59 year old female diagnosed with lumbar and thoracic degeneration, stenosis, multiple cervical foraminal narrowing,
chronic pain in the cervical and lower lumbar regions, bipolar disorder, and history of alcoholism. Opioid Risk Tool score is 12. Medications
include: Vicodin, Ibuprofen, Neurontin, Trazadone, Lamictal, Xanax, and Carisoprodol.
Recommendations from Consultants:
1

Taper Hydrocodone.

2

Taper Carisoprodel slowly.

3

Taper Alprazolam slowly.

4

Complete PHQ-4 screening tools.

5

Assess Prescription Monitoring Link for Washington State (to determine if patient is obtaining prescriptions from other providers in
the state) and obtain urine drug screen to confirm.

6

Recommend to not pursue interventional therapy as unlikely patient will benefit.

7

Behavioral support (MSW or clinical psychologist) for cognitive behavioral approach to help manage symptoms and life.

8

Education on how to use proper body mechanics, i.e., physical therapy, yoga, or tai chi.

Follow-up Presentation: Patient accepted all of the recommendations provided above.

NIH-PA Author Manuscript

1

Hydrocodone taper continues; currently decreased to twice a day dose.

2

Carisprodel taper use has decreased by 50% (15 tablets/month).

3

Alprazolam tapered to 0.25mg/day

4

Lamictal stopped

5

PHQ-4 results is a “4”.

6

Prescription Monitoring Link did not reveal other providers writing opioid prescriptions and urine drug screen is negative.

7

Evaluated by community mental health ARNP and patient is not bipolar; now seeing psychologist for behavioral support.

Follow-up Recommendations from Consultants:
1

Continue to taper Hydrocordone, Carisprodel, and Alprazolam.

2

Endorse clinical psychologist efforts underway.

3

Discussion and plan for “flare” self-management including strategies for pain and mood.
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X
X
X
X

HUI-342–45 (quality of life)

Health Resource Utilization Survey46

Caregiving Time48

Work Productivity and Activity Impairment Questionnaire47

b ,d

d

d

d

c

c

KnowPain

1235

Perceived Competency

Scale37

Knowledge and Attitudes Scale36

Provider Outcomes

X

X

X

X

b

c

X

Fatigue, shortness of breath, constipation numerical scales

b

(anxiety & depression)

X

PHQ-438,39

Baseline

Pain Intensity, Enjoyment of Life, and Interference with General Activity (PEG) Numeric scales40

Patient Outcomes

Study Measures

a

Aim
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Primary Study Measures

X

X

1, 3, 5, 7 weeks (Intervention
patients only)

X

X

X

X

X

X

X

2, 4, 6 weeks

X

X

X

X

X

X

X

8 weeks
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X

X

X

X

X

X

X

X

X

X

12 weeks
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